Cognitive Behavioral Treatments for Depression in Chronic Illness
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Duke University Medical Center in collaboration with Glendale Adventist Medical Center propose a randomized clinical trial of conventional cognitive behavior therapy (CCBT) vs. religious cognitive behavior therapy (RCBT) for major depression in medical patients with chronic disabling illness. Therapists will deliver the treatment in real time over the Internet and/or by telephone to increase treatment access. This planning grant seeks support for a two-site study (North Carolina and California) that consists of two phases. In Phase I (Rounsaville 1a) the investigators will conduct an open trial of 30 patients to assess subject recruitment, refine RCBT and CCBT manuals and protocol, assess compliance with treatment, acceptability of treatment and delivery system (online vs. telephone), and allow therapists gain experience with delivery system and RCBT.
In Phase II (Rounsaville 1b) the investigators will conduct a randomized proof of concept comparison of CCBT vs. RCBT that will demonstrate feasibility and confirm the expected clinically meaningful difference for a definitive R01 application. In Phase II, 70 religious patients ages 18-85 with a new episode of major depression (MINI), scores of 16-35 on the Beck Depression Inventory (BDI), and at least one chronic disabling medical illness will be randomized to either CCBT or RCBT. The trial will consist of ten 50 min sessions administered by master's level therapists and delivered over 12 weeks. The primary endpoint will be BDI score at baseline, 4, 8, 12, and 24-week follow-up. Christian, Jewish, Hindu, Buddhist, and Muslim versions of the RCBT manual will be developed, and CBT experts in each of these traditions will supervise therapists delivering the intervention to patients from these faith traditions.
The purpose of this study is to determine feasibility and effect sizes for a future, fully powered treatment study. The importance is that results will be relevant to therapists well beyond those who explicitly practice pastoral counseling, extending to many secular therapists as well. If 65% of Americans indicate that religion is an important part of daily life and the vast majority of chronically ill medical patients wish to include it in their therapy, then all therapists (whether they have explicit training in pastoral counseling or not) are likely to encounter patients in which this approach would be applicable.
| Condition | Intervention | Phase |
|---|---|---|
|
Major Depression |
Behavioral: Conventional cognitive behavioral therapy Behavioral: Religious cognitive behavioral therapy |
Phase 1 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | Cognitive Behavioral Treatments for Depression in Patients With Chronic Illness |
- Beck Depression Inventory [ Time Frame: Baseline ] [ Designated as safety issue: Yes ]Quantitative assessment of depressive symptoms
- Beck Depression Inventory [ Time Frame: 4 weeks ] [ Designated as safety issue: Yes ]Quantitative assessment of depressive symptoms
- Beck Depression Inventory [ Time Frame: 8 weeks ] [ Designated as safety issue: Yes ]Quantitative assessment of depressive symptoms
- Beck Depression Inventory [ Time Frame: 12 weeks ] [ Designated as safety issue: Yes ]Quantitative assessment of depressive symptoms
- Beck Depression Inventory [ Time Frame: 24 weeks ] [ Designated as safety issue: Yes ]Quantitative assessment of depressive symptoms
- Duke Social Support Index (abbreviated) [ Time Frame: Baseline ] [ Designated as safety issue: No ]Measures amount of social support and satisfaction with it.
- Duke Social Support Index (abbreviated) [ Time Frame: 12 weeks ] [ Designated as safety issue: No ]Measures amount of social support and satisfaction with it
- Duke Social Support Index [ Time Frame: 24 weeks ] [ Designated as safety issue: No ]Measures amount of social support and satisfaction with it.
| Estimated Enrollment: | 100 |
| Study Start Date: | April 2011 |
| Estimated Study Completion Date: | January 2014 |
| Estimated Primary Completion Date: | January 2014 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Conventional cognitive behavioral therapy
Subjects randomized to this arm will receive conventional cognitive behavioral therapy for the treatment of major depression
|
Behavioral: Conventional cognitive behavioral therapy
Conventional cognitive behavioral therapy is a standard treatment for depression. There will be ten 50-minute sessions delivered.
|
|
Experimental: Religious cognitive behavioral therapy
Subjects randomized to this arm will receive conventional cognitive behavioral therapy, but their religious beliefs will be utilized as a resource in the therapy
|
Behavioral: Religious cognitive behavioral therapy
Religious cognitive behavioral therapy is conventional cognitive behavioral therapy that includes consideration of the patient's religious beliefs in therapy. Subjects will receive ten 50-min sessions of therapy
|
Eligibility| Ages Eligible for Study: | 18 Years to 85 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- chronic disabling medical illness
- religion at least somewhat important to patient
- major depressive disorder by MINI neuropsychiatric interview
- Beck Depression Inventory scores of 16-28 (moderately severe depression)
- live near Durham, North Carolina, or near Glendale, in Southern California
Exclusion Criteria:
- significant cognitive impairment
- significant suicidal thoughts or risk
- no access to telephone
Contacts and Locations| Contact: Harold G. Koenig, MD | 919-681-6633 | Harold.Koenig@duke.edu |
| Contact: Bruce Nelson, MA | 818-546-5688 | nelsonbr@ah.org |
| United States, California | |
| Glendale Adventist Medical Center | Recruiting |
| Glendale, California, United States, 91201 | |
| Contact: Sally Shaw, Ph.D. 818-409-8547 ShawSF@ah.org | |
| Contact: Bruce Nelson 818-409-8008 nelsonbr@ah.org | |
| Principal Investigator: Jack Yu, MD | |
| Sub-Investigator: Bruce Nelson, MA | |
| United States, North Carolina | |
| Duke University Medical Center | Recruiting |
| Durham, North Carolina, United States, 27710 | |
| Contact: Harold G. Koenig, MD 919-949-3854 koenig@geri.duke.edu | |
| Contact: Betsy Barton, MPH 919-323-1349 betsy.cbt@duke.edu | |
| Principal Investigator: Harold G Koenig, MD | |
| Sub-Investigator: Harvey J Cohen, MD | |
| Principal Investigator: | Harold G Koenig, MD | Duke University |
More Information
Publications:
| Responsible Party: | Harold Koenig, Professor of Psychiatry and Behavioral Sciences, Duke University |
| ClinicalTrials.gov Identifier: | NCT01208428 History of Changes |
| Other Study ID Numbers: | Pro00026533 |
| Study First Received: | September 22, 2010 |
| Last Updated: | November 15, 2012 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Duke University:
|
Depression |
Additional relevant MeSH terms:
|
Chronic Disease Depression Depressive Disorder Depressive Disorder, Major Disease Attributes |
Pathologic Processes Behavioral Symptoms Mood Disorders Mental Disorders |
ClinicalTrials.gov processed this record on May 16, 2013